Sukses Main Mahjong Ways Best808 Pahami Scatter dan Kombinasinya Mahjong Ways Best808 Simbol Scatter Meningkatkan Peluang Menang Kesalahan Umum Pemain Mahjong Ways di Best808 Auto Jackpot Strategi Terbaik Fitur Scatter Mahjong Ways Best808 Mahjong Ways Best808 Panduan Scatter Wild Hasil Maksimal Pola Mahjong Ways Best808 Gacor Scatter Menang Bongkar Misteri Mahjong Ways Best808 Kunci Kemenanganmu Mau Cuan Maksimal di Mahjong Ways Best808 Trik Menggunakan Scatter Agar Lebih Untung Main Mahjong Ways di Best808 Kenali Pola Scatter Free Spin Gandakan Kemenanganmu Rahasia Scatter Mahjong Ways Best808 Strategi Jitu Menang Jackpot Besar Misteri Scatter Mahjong Ways Tol777 Kunci Jackpot Besar Bongkar Rahasia Mahjong Ways Tol777 Fitur Scatter Pola Menang Mahjong Ways Tol777 Simbol Scatter Kemenangan Besar Main Mahjong Ways di Tol777 Cara Memanfaatkan Scatter Strategi Mahjong Ways Tol777 Rahasia Scatter Trik Menang Jackpot Analisis Pola Permainan Mahjong Ways Keunggulan Mahjong Ways Tol777 vs Tradisional Kombinasi Simbol Tertinggi Mahjong Ways Langkah Meningkatkan Keahlian Mahjong Ways Mahjong Ways Tol777 Berbeda dari Permainan Mengapa Mahjong Ways Tol777 Diminati Dunia Optimalkan Putaran Mahjong Ways Tol777 Sejarah Mahjong Ways Tol777 dan Keunikan Simbol Mahjong Ways Tol777 dan Pemanfaatannya Strategi Lanjutan Mahjong Ways Tol777 Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Cara Cepat Kuasai Mahjong Ways Tol777 Mengapa Mahjong Ways Tol777 Populer Mitos & Fakta Mahjong Ways Tol777 Strategi Pemula vs Pro Mahjong Ways Teknik Profesional Mahjong Ways Tol777 Mahjong Ways Tol777: Keberuntungan atau Skill? Mahjong Ways Tol777: Tradisi dan Inovasi Panduan Mahjong Ways Tol777 untuk Pemula Rahasia Menang Mahjong Ways Tol777 Tips Efektif Main Mahjong Ways Tol777 Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online main mahjong ways di malam hari jackpot profit mengamati permainan mahjong ways dengan baik dan benar merasa bosan pada malam hari? coba cara bermain mahjong ways ini minum kopi memotivasi bermain mahjong ways nelayan tebing tinggi pola mahjong ways hasil mencengangkan pelajar bandung download mahjong ways peluang besar trik dan pola mahjong ways pemuda belanda tato mahjong ways mengenang jackpot satu miliar pola rtp mahjong ways terbaik resep bermain mahjong ways dengan mudah slot mahjong ways dikenal sejak abad ke-11 hingga zaman milenial video mahjong ways viral menghebohkan warga indonesia warga jayamakmur dulu diremehkan, bermain mahjong ways hidup berlimpah harta unik keren bali cendera mata mahjong ways rp100000 warga bingung merek cat dinding sama mahjong ways RTP LIVE RTP LIVE RTP LIVE RTP LIVE RTP LIVE RTP LIVE RTP LIVE RTP LIVE RTP LIVE RTP LIVE RTP Live Mesin Gachor RTP Live Mesin Gachor RTP Live Mesin Gachor RTP Live Mesin Gachor RTP Live Mesin Gachor RTP Live Mesin Gachor RTP Live Mesin Gachor RTP Live Mesin Gachor RTP Live Mesin Gachor RTP Live Mesin Gachor Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Mesin RTP Live SEO Kacau Fitur Menarik Mahjong Ways BIL99 Menang Kejutan Mahjong Ways BIL99 Fitur Wajib Maksimalkan Putaran Mahjong Ways BIL99 Menang Menguasai Fitur Mahjong Ways BIL99 Menang Panduan Pemain Berpengalaman Mahjong Ways BIL99 Panduan Setiap Putaran Mahjong Ways BIL99 Strategi Unggulan Mahjong Ways BIL99 Tips Mengalahkan Lawan Mahjong Ways BIL99 Trik Ampuh Mahjong Ways BIL99 Putaran Trik Cerdas Peluang Menang Mahjong Ways BIL99 Mesin Rtp Live Mesin Rtp Live Mesin Rtp Live Mesin Rtp Live Mesin Rtp Live Mesin Rtp Live Mesin Rtp Live Mesin Rtp Live Mesin Rtp Live Mesin Rtp Live mesin kasino mesin kasino mesin kasino mesin kasino mesin kasino mesin kasino mesin kasino mesin kasino mesin kasino mesin kasino

The Good, The Bad, And The NICE: A Cautionary Tale For Government Negotiation

One of the cornerstones of Great Britain’s National Health Service is an agency that approves and controls access to prescription drugs, the National Institute for Health and Care Excellence.

NICE recently announced a new policy that could delay and restrict access to new medicines for British citizens if the agency deems they don’t pass its “budget impact test.” A drug may be approved as safe and effective, but patients could still wait for years to get it if the agency believes the cost could exceed a certain total threshold.

“Thousands of patients will wait longer for treatment for conditions like heart disease, cancers and diabetes while medicines which stand to benefit the most people are caught up in the system,” according to the head of the British Association of the Pharmaceutical Industry Mike Thompson.

“Use of new medicines in the UK is already poor, with [British] patients seven times more likely to get a newly launched medicine in places like Germany or France.” Predictably, UK patient groups have expressed outrage and dismay, warning that this proposal will sentence thousands of patients to an early death.

Why is this relevant in the United States? NICE’s intervention is made possible because this single government body has the authority to decide which medicines will be reimbursed and available to patients.

But, proponents argue, NICE can obtain lower prices for medicines. That is for the simple reason that it is the only game in town. That’s what “government negotiation” means. It is the equivalent of the Godfather making “an offer you can’t refuse.”

The downside is that the government makes the call on when, what, and for whom treatments will be available, guided by political and budgetary considerations.

NICE shows the underside of government exercising its power to purchase or not purchase drugs and set prices.

On this side of the Atlantic, we see another government program that shows how access to medicines can be advanced while keeping costs down—the Medicare Prescription Drug Benefit program, or Part D.

Since Medicare Part D began operating in 2006, it has consistently outperformed budget projections, and nearly 9 out of 10 seniors say they are satisfied or highly satisfied with the program. It works because private health plans negotiate with pharmaceutical manufacturers for the best prices and, just as importantly, they compete with each other to offer the lowest prices and best benefit structure to seniors.

Seniors can select the plan that offers the drugs they need while still knowing they have protection if their doctors prescribe other medicines, choosing from more than 150 categories of drugs covered under each plan.

Consumer choice and competition are key.

Seniors pay an average of $34 a month for their Part D prescription drug coverage this year, about half the amount they were expected to be paying at this point, more than 10 years after the program began. Some seniors pay nothing for their drug benefit because it is folded into comprehensive private Medicare Advantage plans. Taxpayers also are saving money, with the cost of the program coming in about half what the Congressional Budget Office had projected.

In some cases, private competition actually reduces prices below what is paid by countries that impose government price controls. For example, drugs that can cure Hepatitis C are now available for lower prices in the U.S. than in many European countries.

Price controls take many forms, and government “price negotiations” is one of them. Governments don’t negotiate; they dictate prices. That might work in the short term, but price controls quickly lead to shortages and, in the long term, to a significant loss of innovation.

That isn’t stopping talk of allowing the U.S. government to negotiate prices in Medicare Part D. But that would be another step toward a NICE-like system in the United States where a government entity explicitly says that if they don’t like the price of a drug, it won’t be available to you.

The designated head of the Food and Drug Administration, Dr. Scott Gottlieb, faces the Senate for his confirmation hearings this week. He has many tools in his medical bag to help make drugs more affordable, including modernizing the FDA approval process, removing barriers to contracting based upon value and outcomes, and creating a pathway for more competition in generic drugs.

And for seniors, the key is to protect the Part D model where sophisticated private purchasers have proven they can negotiate very effectively on behalf of millions of seniors and allow them to choose the drugs they need, not have the government decide which ones it will make available.

Ask patients in the UK about their access to new medicines, and they can tell you just how bad NICE can be.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top